600351.SS
Price:
$6.25
Market Cap:
$4.38B
Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, APIs, and pharmaceutical packaging materials in China and internationally. The company provides products for pediatrics, female healthcare, cardiovascular, big health, and elderly chronic diseases under the Diarrago, Baiyu, and Yabao brands. It also offers plastic bottles and cartons. The company provides its products in the form of injections, tablets, capsules, granules, pills, patches, freeze-dried powders, mixtures, suppositories, and solutions. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Yuncheng, China.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2002-09-26
Stock Exchange
SHH
Ticker
600351.SS
According to Yabao Pharmaceutical Group Co., Ltd’s latest financial reports and current stock price. The company's current PE Ratio is 18.38. This represents a change of -60.35% compared to the average of 46.36 of the last 4 quarters.
The mean historical PE Ratio of Yabao Pharmaceutical Group Co., Ltd over the last ten years is 101.62. The current 18.38 PE Ratio has changed 1.71% with respect to the historical average. Over the past ten years (40 quarters), 600351.SS's PE Ratio was at its highest in in the December 2015 quarter at 176.20. The PE Ratio was at its lowest in in the December 2022 quarter at -413.04.
Average
101.62
Median
36.54
Minimum
15.96
Maximum
415.71
Discovering the peaks and valleys of Yabao Pharmaceutical Group Co., Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.50%
Maximum Annual PE Ratio = 415.71
Minimum Annual Increase = -91.49%
Minimum Annual PE Ratio = 15.96
Year | PE Ratio | Change |
---|---|---|
2024 | 17.91 | -32.51% |
2023 | 26.54 | -38.66% |
2022 | 43.26 | 15.77% |
2021 | 37.37 | 4.64% |
2020 | 35.71 | -91.41% |
2019 | 415.71 | 2.50% |
2018 | 15.96 | -45.71% |
2017 | 29.40 | -91.49% |
2016 | 345.61 | 610.12% |
2015 | 48.67 | 39.37% |
The current PE Ratio of Yabao Pharmaceutical Group Co., Ltd (600351.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
29.24
5-year avg
32.16
10-year avg
101.62
Yabao Pharmaceutical Group Co., Ltd’s PE Ratio is greater than Joincare Pharmaceutical Group Industry Co.,Ltd. (14.75), greater than Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (11.11), greater than Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (16.32), less than Zhejiang Hisun Pharmaceutical Co., Ltd. (18.95), greater than Henan Lingrui Pharmaceutical Co., Ltd. (17.75),
Company | PE Ratio | Market cap |
---|---|---|
14.75 | $19.68B | |
11.11 | $21.60B | |
16.32 | $41.46B | |
18.95 | $10.59B | |
17.75 | $13.15B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Yabao Pharmaceutical Group Co., Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Yabao Pharmaceutical Group Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Yabao Pharmaceutical Group Co., Ltd's PE Ratio?
How is the PE Ratio calculated for Yabao Pharmaceutical Group Co., Ltd (600351.SS)?
What is the highest PE Ratio for Yabao Pharmaceutical Group Co., Ltd (600351.SS)?
What is the 3-year average PE Ratio for Yabao Pharmaceutical Group Co., Ltd (600351.SS)?
What is the 5-year average PE Ratio for Yabao Pharmaceutical Group Co., Ltd (600351.SS)?
How does the current PE Ratio for Yabao Pharmaceutical Group Co., Ltd (600351.SS) compare to its historical average?